Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06486077 · ClinicalTrials.gov registry record · NA
Metabolic Health 1: Power Line Evaluation; Effect Size Determination
A NA study of Metabolic Health, sponsored by Nature's Sunshine Products.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT06486077: Completed NA study of Metabolic Health, sponsored by Nature's Sunshine Products.
NCT06486077 is a NA study of Metabolic Health that has completed, run by Nature's Sunshine Products. The registered enrollment target is 17 participants, below the 50,143-participant average among 10 other Metabolic Health trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06486077, a NA study of Metabolic Health, has completed, sponsored by Nature's Sunshine Products.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary goal of this study is to demonstrate the safety and tolerability of the Power Line program, an integrated, whole-food supplement system. Secondarily, it is desired to determine the effect size of this program on maintenance of markers of metabolic health, with a particular emphasis on insulin sensitivity and dyslipidemia.
Primary Outcome
Data collection at individual study visits (Visit 1- baseline, Visit 2 - Day 30, and Visit 3 - Day 90) will be used to assess participants for supplementation program-related adverse events. Subjects with ongoing AEs may be followed until resolution at the discretion of the PI.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Power Line Program
Study Locations (1)
Utah
- The Hughes Center for Research and Innovation - Lehi
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2025-05-20 |
| Est. Completion | 2025-11-28 |
| Phase | NA |
What the finished NCT06486077 record still lists
NCT06486077 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 50,143-participant average among 10 other Metabolic Health trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Metabolic Health appearing as the primary indexed condition, and to 1 intervention - of which Power Line Program is the first listed.
NCT06486077 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT06486077 about?
NCT06486077 is a clinical study titled "Metabolic Health 1: Power Line Evaluation; Effect Size Determination". The primary goal of this study is to demonstrate the safety and tolerability of the Power Line program, an integrated, whole-food supplement system. Secondarily, it is desired to determine the effect size of this program on maintenance of markers of metabolic health, with a particular emphasis on in...
What is the current status of trial NCT06486077?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2025-05-20. Estimated completion is 2025-11-28.
What conditions does trial NCT06486077 study?
This clinical trial studies the following conditions: Metabolic Health.
What interventions are being tested in trial NCT06486077?
The interventions under investigation include: Power Line Program (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06486077?
This trial is sponsored by Nature's Sunshine Products, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06486077 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metabolic Health
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06486077's enrollment target sits among peer trials
17 11th of 10 the lowest of 10 other Metabolic Health trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Metabolic Health trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Viome Nutritional Programs to Improve Clinical Outcomes for Metabolic Conditions
RECRUITING · NA
-
Women's Hormonal and Metabolic Wellbeing Study
RECRUITING · NA
-
Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project
RECRUITING · NA
-
Study to Evaluate the Efficacy of an Avocado Dietary Supplement
ACTIVE NOT RECRUITING · NA
-
Impact of Protein Source and Polyphenol Complexation in Protein Bars on Metabolic Health
ACTIVE NOT RECRUITING · NA
-
Effects of a Synbiotic Supplement on Metabolic & Cognitive Outcomes Among Older Adults
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI